Biosensors for the detection of bacterial and viral clinical pathogens

L Castillo-Henríquez, M Brenes-Acuña, A Castro-Rojas… - Sensors, 2020 - mdpi.com
Biosensors are measurement devices that can sense several biomolecules, and are widely
used for the detection of relevant clinical pathogens such as bacteria and viruses, showing …

Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus

J Li, S Li, L Yang, P Cao, J Lu - Critical Reviews in Microbiology, 2021 - Taylor & Francis
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel bunyavirus. Since
2007, SFTS disease has been reported in China with high fatality rate up to 30%, which …

Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey

P Vinck, PN Pham, KK Bindu, J Bedford… - The Lancet Infectious …, 2019 - thelancet.com
Background The current outbreak of Ebola in eastern DR Congo, beginning in 2018,
emerged in a complex and violent political and security environment. Community-level …

Pandemics–One Health preparedness for the next

FM Aarestrup, M Bonten, M Koopmans - The Lancet Regional Health …, 2021 - thelancet.com
The majority of emerging infectious diseases originate in animals. Current routine
surveillance is focused on known diseases and clinical syndromes, but the increasing …

Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined …

D Ishola, D Manno, MO Afolabi, B Keshinro… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background The Ebola epidemics in west Africa and the Democratic Republic of
the Congo highlight an urgent need for safe and effective vaccines to prevent Ebola virus …

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach

M Alizadeh, H Amini-Khoei, S Tahmasebian… - Scientific reports, 2022 - nature.com
Ebola virus (EBOV) is a dangerous zoonotic infectious disease. To date, more than 25 EBOV
outbreaks have been documented, the majority of which have occurred in Central Africa …

Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus

K Dhama, K Karthik, R Khandia, S Chakraborty… - Frontiers in …, 2018 - frontiersin.org
Ebola virus (EBOV), a member of the family Filoviridae, is responsible for causing Ebola
virus disease (EVD)(formerly named Ebola hemorrhagic fever). This is a severe, often fatal …

Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor

Q Cui, R Du, M Anantpadma, A Schafer, L Hou, J Tian… - Viruses, 2018 - mdpi.com
The recent 2014–2016 West African Ebola virus epidemic underscores the need for the
development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus …

Politicizing public health: The powder keg of rushing COVID-19 vaccines

RJ Limaye, M Sauer, SA Truelove - Human Vaccines & …, 2021 - Taylor & Francis
Vaccine hesitancy is on the rise, as more individuals are delaying or refusing vaccines. This
rise in hesitancy has been primarily driven by vaccine safety concerns, even though the …

Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal …

JD Kelly, C Van Ryn, M Badio, T Fayiah… - The Lancet Infectious …, 2022 - thelancet.com
Background Whether or not individuals with pauci-symptomatic or asymptomatic Ebola virus
infection and unrecognised Ebola virus disease develop clinical sequelae is unknown. We …